Advisers to the Food and Drug Administration meet Tuesday to review the first treatment of human disease using the gene-editing technique CRISPR. The agency has a December deadline to make a decision.
×
Advisers to the Food and Drug Administration meet Tuesday to review the first treatment of human disease using the gene-editing technique CRISPR. The agency has a December deadline to make a decision.